期刊文献+

Serum levels of macrophage migration inhibitory factor,Interleukin-17 and Interleukin-10 in patients with HBV-related liver disease 被引量:10

Serum levels of macrophage migration inhibitory factor,Interleukin-17 and Interleukin-10 in patients with HBV-related liver disease
暂未订购
导出
摘要 Objective To study the potential role of macrophage migration inhibitory factor(MIF),Interleukin-17(IL-17) and Interleukin-10(IL-10) in the development of HBV-related liver disease.Methods 48 patients with chronic hepatitis B(HBeAg negative and positive,24 cases;21cases of HBV-DNA negative and 27 cases of HBV-DNA positive),81 cases of hepatitis B patients with decompensated cirrhosis and 48 cases of primary liver cancer patients were collected as the experimental group,26 healthy people were as control group.Serum MIF,IL-17 and IL-10 were measured.Results MIF and IL-17 significantly increased,IL-10 significantly decreased in experimental group,compared with the control group(P<0.05),there was significant difference.In addition,there was no significant difference(P>0.05) between positive and negative of chronic hepatitis B.MIF,IL-17 and ALT levels were positively correlated(r=0.693,P<0.01;r=0.897,P<0.001),IL-10 and ALT was negatively correlated(r =-0.285,P=0.037).Conclusion These results indicated that MIF,IL-17 and IL-10 may participate in the pathological process of HBV-related liver disease,serum levels of MIF,IL-17 and IL-10 appear to reflect the severity of tissue injury in HBV-related liver disease. Objective To study the potential role of macrophage migration inhibitory factor (MIF), Interleukin-17 (IL-17) and Interleukin-10 (IL-10) in the development of HBV-related liver disease. Methods 48 patients with chro- nic hepatitis B (HBeAg negative and positive, 24 cases; 21cases of HBV-DNA negative and 27 cases of HBV-DNA pos- itive) , 81 cases of hepatitis B patients with deeompensated cirrhosis and 48 cases of primary liver cancer patients were collected as the experimental group, 26 healthy people were as control group. Serum MIF, IL-17 and IL-10 were meas- ured. Results MIF and IL-17 significantly increased, IL-10 significantly decreased in experimental group, compared with the control group (P 〈 0.05) , there was significant difference. In addition, there was no significant difference (P 〉 0.05) between positive and negative of chronic hepatitis B. MIF, IL-17 and ALT levels were positively correlated (r=0.693, P〈O. 01; r=0.897, P〈O. O01), IL-IO and ALT was negatively correlated (r = -0. 285, P=0.037). Conclusion These results indicated that MIF, IL-17 and IL-10 may participate in the pathological process of HBV-re- lated liver disease, serum levels of MIF, IL-17 and IL-10 appear to reflect the severity of tissue injury in HBV-related liver disease.
出处 《胃肠病学和肝病学杂志》 CAS 2012年第6期560-563,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 supported by grants from the Natural Science Foundation of Gansu Province of China
关键词 MIF IL-17 IL-10 HBV-related liver disease MIF IL-17 IL-10 HBV-related liver disease
  • 相关文献

参考文献4

二级参考文献67

  • 1Wei Zhang,Bei Yue,Gui-Qiang Wang,Shu-Lan Lu the Department of Infectious Dispeases, Ruijing Hospital, Shanghai Second Medical University, Shanghai 200025, China Department of Intectious Diseases, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China.Serum and ascites levels of macrophage migration inhibitory factor, TNF-α and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):577-580. 被引量:18
  • 2Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 [ J]. Nat Immunol, 2005, 6(11) : 1133 - 1141.
  • 3Laan M, Palmberg L, Larsson K, et al. Free, soluble interleukin-17 protein during severe inflammation in human airways [ J ]. Eur Respir J, 2002, 19(3) : 534 -537.
  • 4Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression[J]. J Allergy Clin Immunol, 2003, 111 (6) : 1293 - 1298.
  • 5Chabaud M, Lubberts E, Joosten L, et al. IL-17 derived from juxtaarticular bone and synovium contributes to joint degradation in rheumatoid arthritis[J]. Arthritis Res, 2001, 3(3) : 168 -177.
  • 6Fujino S, Andoh A, Bamba S, et al. Increased expression of interleukin 17 in inflammatory bowel disease[ J ]. Gut, 2003,52 (1) : 65 -70.
  • 7Casini A, Pinzani M, Milani S, et al. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells[ J]. Gastroenterology, 1993, 105 ( 1 ) : 245 - 253.
  • 8Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines [J]. JAllergy Clin Immunol, 2001, 108(3) : 430 -438.
  • 9WHO.Hepatitis B[R].WHO/CDS/CSR/LYO/2002.2:Hepatitis B,2002:1-25.
  • 10Lok AS.Chronic hepatitis B[J].N Engl J Med,2002,346 (9):1682-1683.

共引文献44

同被引文献37

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部